Barnard Neal D, Levin Susan, Crosby Lee, Flores Rosendo, Holubkov Richard, Kahleova Hana
George Washington University School of Medicine & Health Science; Physicians Committee for Responsible Medicine, Washington, DC, USA.
Physicians Committee for Responsible Medicine, Washington, DC, USA.
Am J Lifestyle Med. 2022 Apr 3;19(2):266-275. doi: 10.1177/15598276221081819. eCollection 2025 Feb.
To investigate the effects of a dietary intervention on arthritis pain and disease severity, 44 adults previously diagnosed with rheumatoid arthritis were randomly assigned to a Diet phase (vegan diet for 4 weeks, elimination of additional foods for 3 weeks, and then reintroduction of the eliminated foods individually over 9 weeks) or a Supplement (placebo) phase for 16 weeks. After a 4-week washout, they then switched to the opposite phase. The Disease Activity Score-28 (DAS28) decreased from 4.5 to 2.5 (P < .001) in the Diet phase and from 3.2 to 2.9 (P = .41) in the Supplement phase (between-group P = .01). The mean number of swollen joints decreased from 7.0 to 3.3 in the Diet phase (P = .03) and increased from 4.7 to 5 in the Supplement phase (P = .63; between-group P = .047). In a subanalysis excluding individuals who increased medications during the study, DAS28 decreased 1.9 points in the Diet phase (P = .003) and .4 points in the Supplement phase (P = .27; between-group P = .04). In a further subanalysis limited to participants making no medication changes, DAS28 decreased 1.5 points in the Diet phase (P = .009) and .3 points in the Supplement phase (P = .40, between-group P = .11). We conclude that the dietary intervention was associated with symptomatic improvements. TRIAL REGISTRATION: Clinicaltrials.gov NCT01544101, NCT01700881, NCT03417648, and NCT03580681.
为研究饮食干预对关节炎疼痛及疾病严重程度的影响,44名先前被诊断为类风湿性关节炎的成年人被随机分配至饮食阶段(纯素饮食4周,禁食其他食物3周,然后在9周内逐个重新引入禁食食物)或补充剂(安慰剂)阶段,为期16周。经过4周的洗脱期后,他们切换至相反阶段。疾病活动评分-28(DAS28)在饮食阶段从4.5降至2.5(P <.001),在补充剂阶段从3.2降至2.9(P = .41)(组间P = .01)。饮食阶段肿胀关节的平均数量从7.0降至3.3(P = .03),补充剂阶段从4.7增至5(P = .63;组间P = .047)。在一项排除研究期间增加用药的个体的亚分析中,DAS28在饮食阶段下降了1.9分(P = .003),在补充剂阶段下降了0.4分(P = .27;组间P = .04)。在另一项仅限于未改变用药的参与者的亚分析中,DAS28在饮食阶段下降了1.5分(P = .009),在补充剂阶段下降了0.3分(P = .40,组间P = .11)。我们得出结论,饮食干预与症状改善相关。试验注册:Clinicaltrials.gov NCT01544101、NCT01700881、NCT03417648和NCT03580681。